FSCS Among Mid Cap ETFs
End-of-day Nov 18, 2026 · 93 Mid cap ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −2.5% | +0.6% | −1.6% | +4.7% | +8.3% | +43.0% | +29.9% | — | +114.4% |
| Peer average | +0.3% | −3.6% | −1.7% | −4.9% | +9.9% | +15.8% | +56.9% | +35.7% | +187.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$12 of every $1,000 in FSCS is Neurocrine
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | NBIXNeurocrine Biosciences | Healthcare | 1.20% | $119.67 | 4,415 | $733K |
| 2 | HASHasbro | Consumer Cyclical | 1.19% | $118.50 | 6,129 | $725K |
| 3 | ALLEAllegion Public Limited Company | Industrials | 1.18% | $118.15 | 3,872 | $723K |
| 4 | VLTOVeralto | Industrials | 1.16% | $115.75 | 5,985 | $709K |
| 5 | HCSGHealthcare Services Group | Healthcare | 1.15% | $114.89 | 28K | $703K |
| 6 | IPARInterparfums | Consumer Defensive | 1.13% | $113.36 | 5,239 | $694K |
| 7 | JAZZJAZZ Pharmaceuticals | Healthcare | 1.13% | $113.30 | 2,881 | $693K |
| 8 | ROLRollins | Industrials | 1.12% | $112.35 | 18K | $688K |
| 9 | CPAYCorpay | Technology | 1.12% | $112.17 | 1,518 | $687K |
| 10 | AIZAssurant | Financial Services | 1.12% | $112.11 | 2,130 | $686K |
| 11 | ACIWACI Worldwide | Technology | 1.12% | $112.07 | 12K | $686K |
| 12 | CPRTCopart | Industrials | 1.11% | $110.87 | 22K | $679K |
| 13 | PPGPPG Industries | Basic Materials | 1.10% | $110.24 | 5,585 | $675K |
| 14 | CINFCincinnati Financial | Financial Services | 1.10% | $109.54 | 3,549 | $670K |
| 15 | TXRHTexas Roadhouse | Consumer Cyclical | 1.09% | $109.32 | 3,593 | $669K |
of the $519B in 108 Mid cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | NBIX | Neurocrine Biosciences | 1.20% |
| 2 | HAS | Hasbro | 1.19% |
| 3 | ALLE | Allegion Public Limited Company | 1.18% |
| 4 | VLTO | Veralto | 1.16% |
| 5 | HCSG | Healthcare Services Group | 1.15% |
| 6 | IPAR | Interparfums | 1.13% |
| 7 | JAZZ | JAZZ Pharmaceuticals | 1.13% |
| 8 | ROL | Rollins | 1.12% |
| 9 | CPAY | Corpay | 1.12% |
| 10 | AIZ | Assurant | 1.12% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.14 |
| Jun 25, 2026 | Jun 30, 2026 | $0.12 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0936 |
| Dec 12, 2025 | Dec 31, 2025 | $0.10 |
| Sep 25, 2025 | Sep 30, 2025 | $0.0494 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0749 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0389 |
| Dec 13, 2024 | Dec 31, 2024 | $0.11 |
| Sep 26, 2024 | Sep 30, 2024 | $0.0695 |
| Jun 27, 2024 | Jun 28, 2024 | $0.16 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0600 |
| Dec 22, 2023 | Dec 29, 2023 | $0.19 |